STAT3 and glioblastoma: In this study, we aimed to (1) characterize the expression of STAT3 in glioma and GBM; (2) elucidate the molecular mechanism of ACT001 with respect to STAT3 and PD-L1; and (3) determine the effect of ACT001 in vivo with respect to antitumor immune response.